McKay v. Novartis Pharmaceuticals Corp.

*900 ORDER ON DEFENDANT’S MOTION FOR SUMMARY JUDGMENT

FRANK MONTALVO, District Judge.

On this day, the court considered Defendant Novartis Pharmaceuticals Corporation’s (“Defendant” or “Novartis”) “Novartis Pharmaceuticals Corporation’s Motion for Summary Judgment and Briefing in Support” (“Motion”) [ECF. No. 32], filed March 27, 2012; Plaintiffs’ Thomas W. McKay and Leticia McKay’s (collectively “Plaintiffs” or “McKays”) “Plaintiffs’ Response in Opposition to Defendant’s Renewed Motion for Summary Judgment” (“Response”) [ECF No. 38], filed April 27, 2012; and Defendant’s “Novartis Pharmaceuticals…